Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial

Volume
51
Pagination
S708 - S709
DOI
10.1016/S0959-8049(16)31927-X
ISSN
0959-8049
Metadata
Show full item record
Authors
Choueiri, T; Escudier, B; Powles, T; Mainwaring, P; Rini, B; Donskov, F; Hammers, H; Hutson, T; Roth, B; Peltola, K
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11011
Collections
Licence information
• “The final publication is available at http://www.nejm.org/doi/full/10.1056/NEJMoa1510016”